Completed NA INTERVENTIONAL 1-arm NCT00301613

Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN

MMF Versus Intravenous CTX Pulses in the Treatment of Adult Severe Henoch-Schonlein Purpura Nephritis

Sponsor: Nanjing University School of Medicine

Conditions Henoch-Schoenlein Purpura Nephritis

Updated 5 times since 2017 Last updated: May 25, 2010 Started: Jan 31, 2003 Primary completion: May 31, 2005 Completion: Jan 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00301613, this NA trial focuses on Henoch-Schoenlein Purpura and Nephritis and remains completed. Sponsored by Nanjing University School of Medicine, it has been updated 5 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nanjing University School of Medicine

Data source: Nanjing University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China